Join to view full profile
RegenxbioIrvington, NY 10533
Dr. Pakola is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Perelman School of Medicine at the University of PennsylvaniaClass of 1994
Certifications & Licensure
NC State Medical License 1997 - 2022
Publications & Presentations
PubMed
- 23 citationsAssociation between anatomical resolution and functional outcomes in the mivi-trust studies using ocriplasmin to treat symptomatic vitreomacular adhesion/vitreomacular...Arnd Gandorfer, Matthew S. Benz, Julia A. Haller, Peter Stalmans, Stephen Pakola
Retina. 2015-06-01 - 114 citationsEfficacy of Intravitreal Ocriplasmin for Treatment of Vitreomacular Adhesion: Subgroup Analyses from Two Randomized TrialsJulia A. Haller, Peter Stalmans, Matthew S. Benz, Arnd Gandorfer, Stephen Pakola
Ophthalmology. 2015-01-01 - 78 citationsA Placebo-Controlled Trial of Microplasmin Intravitreous Injection to Facilitate Posterior Vitreous Detachment before VitrectomyMatthew S. Benz, Kirk H. Packo, Victor H. Gonzalez, Stephen Pakola, Donna Bezner
Ophthalmology. 2010-04-01
Press Mentions
REGENXBIO Reports Third Quarter 2019 Financial and Operating Results and Recent Operational HighlightsNovember 26th, 2019
REGENXBIO Reports First Quarter 2019 Financial and Operating Results and Additional Positive Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMDMay 7th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
